Out-of-Hospital Coagulation Monitoring and Management

[1]  J. Ansell,et al.  Consensus Guidelines for Coordinated Outpatient Oral Anticoagulation Therapy Management , 1997, The Annals of pharmacotherapy.

[2]  J. Ansell,et al.  Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management. , 1996, American heart journal.

[3]  D. Singer,et al.  An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. , 1996, The New England journal of medicine.

[4]  Vittorio Pengo,et al.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) , 1996, The Lancet.

[5]  S. Fihn,et al.  The Risk for and Severity of Bleeding Complications in Elderly Patients Treated with Warfarin , 1996, Annals of Internal Medicine.

[6]  David C. Anderson,et al.  Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators. , 1996, Archives of internal medicine.

[7]  G. Perego,et al.  Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate. , 1996, European heart journal.

[8]  L. Fish,et al.  Long-term patient self-management of oral anticoagulation. , 1995, Archives of internal medicine.

[9]  B. Gersh,et al.  Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota. , 1995, Mayo Clinic proceedings.

[10]  J. Vandenbroucke,et al.  Optimal oral anticoagulant therapy in patients with mechanical heart valves. , 1995, The New England journal of medicine.

[11]  M. Beaudet,et al.  Age-associated risks of prophylactic anticoagulation in the setting of hip fracture. , 1995, The American journal of medicine.

[12]  E. Hylek,et al.  Risk Factors for Intracranial Hemorrhage in Outpatients Taking Warfarin , 1994, Annals of Internal Medicine.

[13]  P. Mannucci,et al.  Are Capillary Whole Blood Coagulation Monitors Suitable for the Control of Oral Anticoagulant Treatment by the International Normalized Ratio? , 1993, Thrombosis and Haemostasis.

[14]  J. Hirsh,et al.  Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. , 1993, Archives of internal medicine.

[15]  Donald Martin,et al.  Risk Factors for Complications of Chronic Anticoagulation: A Multicenter Study , 1993, Annals of Internal Medicine.

[16]  M. Sakon,et al.  Bedside monitoring of warfarin therapy by a whole blood capillary coagulation monitor. , 1992, Thrombosis research.

[17]  S. McCurdy,et al.  Accuracy and precision of a portable anticoagulation monitor in a clinical setting. , 1992, Archives of internal medicine.

[18]  T. Baglin,et al.  Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation. , 1991, Journal of clinical pathology.

[19]  J. Heaf,et al.  Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients , 1991, Journal of internal medicine.

[20]  R. Weibert,et al.  Evaluation of a capillary whole-blood prothrombin time measurement system. , 1989, Clinical pharmacy.

[21]  S A McCurdy,et al.  Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study. , 1989, Annals of internal medicine.

[22]  J. Ansell,et al.  Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times. , 1989, Archives of internal medicine.

[23]  L Goldman,et al.  Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. , 1989, The American journal of medicine.

[24]  L Goldman,et al.  Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions. , 1989, The American journal of medicine.

[25]  G. Clark,et al.  The Safety and Effectiveness of Long‐Term Warfarin Therapy in an Anticoagulation Clinic , 1989, Pharmacotherapy.

[26]  A. Bayer,et al.  Can old people on oral anticoagulants be safely managed as out-patients? , 1988, Postgraduate medical journal.

[27]  J. Gurwitz,et al.  Age-related risks of long-term oral anticoagulant therapy. , 1988, Archives of internal medicine.

[28]  W. Hauser,et al.  Complications of long‐term anticoagulation , 1988, Annals of neurology.

[29]  V. Fuster,et al.  Anticoagulation clinics and the monitoring of anticoagulant therapy. , 1988, International journal of cardiology.

[30]  D. Mungall,et al.  A novel whole blood capillary technic for measuring the prothrombin time. , 1987, American journal of clinical pathology.

[31]  E F Cook,et al.  Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. , 1987, The American journal of medicine.

[32]  G. Mcinnes,et al.  The Performance of Clinics for Out-Patient Control of Anticoagulation , 1987, Journal of the Royal College of Physicians of London.

[33]  J. Ansell,et al.  Management of oral anticoagulant therapy. Experience with an anticoagulation clinic. , 1984, Archives of internal medicine.

[34]  J C Forfar,et al.  Prediction of hemorrhage during long-term oral coumarin anticoagulation by excessive prothrombin ratio. , 1982, American heart journal.

[35]  RISKS OF LONG-TERM ORAL ANTICOAGULANT THERAPY IN ELDERLY PATIENTS AFTER MYOCARDIAL INFARCTION Second Report of the Sixty Plus Reinfarction Study Research Group , 1982, The Lancet.

[36]  F. Davis,et al.  Management of anticoagulation in outpatients: experience with an anticoagulation service in a municipal hospital setting. , 1977, Archives of internal medicine.

[37]  P. W. Willis,et al.  Hemorrhagic complications of anticoagulant therapy. , 1974, Archives of internal medicine.

[38]  J. Ross.  Case of Injury of the Hip, by a Fall, with Exfoliation of the Bone , 1845 .

[39]  Angelika Bernardo M. D..  Post-conference session: Experience with patient self-management of oral anticoagulation , 2005, Journal of Thrombosis and Thrombolysis.

[40]  J. Ansell,et al.  Anticoagulation Management as a Risk Factor for Adverse Events: Grounds for Improvement , 2004, Journal of Thrombosis and Thrombolysis.

[41]  J. Ansell,et al.  Advances in the monitoring of oral anticoagulation: Point-of-care testing, patient self-monitoring, and patient self-management , 2004, Journal of Thrombosis and Thrombolysis.

[42]  J. Vandenbroucke,et al.  Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. , 1993, Archives of internal medicine.

[43]  D. Petitti,et al.  Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin. , 1989, Journal of clinical epidemiology.

[44]  L. S. Wickramasinghe,et al.  Long-term oral anticoagulant therapy in elderly patients. , 1988, Age and ageing.